Results 211 to 220 of about 54,210 (294)

Preparation of Antioxidant Peptides Derived From Quinoa Protein and Evaluation of Their Antioxidant Activity Through a D‐Galactose‐Induced Aging Mice Model

Food Science &Nutrition, Volume 14, Issue 6, June 2026.
Quinoa protein peptides (QPP) were prepared via pepsin hydrolysis and showed strong in vitro antioxidant activity. In D‐galactose‐induced aging mice, QPP alleviated organ damage, enhanced antioxidant enzyme activities, and upregulated hepatic antioxidant gene and protein expression. QPP is a promising natural anti‐aging ingredient for functional foods.
Dandan Gao, Yuxuan Zhang, Hongxin Ma
wiley   +1 more source

Real-World Data of Light Chain (AL) Amyloidosis: Prognostic Indices and Treatment Patterns. [PDF]

Biomedicines
Mitrovic M, Sretenovic A, Kecman N, Vukosavljevic N, Perunicic Jovanovic M, Sobic Saranovic D, Maksimovic R, Bukumiric Z, Lekovic D, Ristic A, Todorovic Balint M, Bila J.   +11 more
europepmc   +1 more source

Teclistamab in relapsed/refractory light chain amyloidosis: A retrospective multicenter study by the German Society for Amyloid Diseases

HemaSphere, Volume 10, Issue 6, June 2026.
Abstract Systemic light chain (AL) amyloidosis is a rare, acquired protein misfolding disorder characterized by extracellular deposition of misfolded immunoglobulin light chain fibrils, resulting in organ damage. Treatment is based on anti‐plasma cell regimens derived from multiple myeloma therapy.
Alexander Carpinteiro, Christoph Kimmich, Despina Trajanova, Ute Hegenbart, Timon Hansen, Udo Holtick, Vera von Landenberg‐Roberg, Stephan Rainer Bohl, Raphael Teipel, Ivana von Metzler, Monika Engelhardt, Evgenii Shumilov, Maximilian Steinhardt, Hans Christian Reinhardt, Sara Oubari, Stefan Schönland   +15 more
wiley   +1 more source

Single-cell and clonal analysis of AL amyloidosis plasma cells and their bone marrow microenvironment. [PDF]

Blood
Gort-Freitas NA, Moscvin M, Da Vià MC, Lazzaroni F, Nevone A, Sadigh S, Boullt S, Evans B, Chen T, Karagiannis T, Tai A, Rowell S, Raghav S, Chen AF, Laubach JP, Edwards C, Aster JC, Sheng Z, Paulo JA, Chan CN, Nuvolone M, Bolli N, Comenzo RL, Klein AM, Bianchi G.   +24 more
europepmc   +1 more source

Dermatological Manifestations of Amyloid Light-Chain (AL) Amyloidosis: A Case Report Highlighting Early Diagnosis and Treatment. [PDF]

Cureus
Gill SS, Kamboj T.
europepmc   +1 more source

Minimally invasive characterization of peripheral blood measurable residual disease in multiple myeloma using high‐sensitivity detection of ctDNA by next‐generation sequencing

HemaSphere, Volume 10, Issue 6, June 2026.
Abstract Measurable residual disease assessment in bone marrow (BM‐MRD) is a crucial prognostic factor in multiple myeloma (MM), but its clinical use has some caveats, such as invasiveness, poor spatial representativity, and serial sampling. Novel minimally invasive approaches for monitoring peripheral residual disease (PRD) could facilitate its ...
Natalia Buenache, Marta Lasa, Andrés Arroyo, Carmen González, Larissa Haertle, Yanira Ruiz‐Heredia, Rosa Ayala, Rafael Alonso, Alejandro Martín‐Muñoz, Juan M. Rosa‐Rosa, Verónica González, María J. Calasanz, Paula Rodríguez‐Otero, Laura Rosiñol, Felipe De Arriba, Enrique M. Ocio, Albert Oriol, Yolanda González, Anna Sureda, Sunil Lakhwani, María E. Clavero, Angela Ibáñez, Clara Gómez, Alberto Orfao, María‐Victoria Mateos, Juan J. Lahuerta, María T. Cedena, Joan Bladé, Jesús San Miguel, Noemi Puig, Bruno Paiva, Joaquín Martínez‐López   +31 more
wiley   +1 more source

Negative [99mTc]Tc -DPD Scintigraphy, Presence of Monoclonal Protein and Biopsy Suggestive of AL Amyloidosis in a Patient With Homozygous p.Ala101Val Transthyretin Gene Variant. [PDF]

Clin Case Rep
Kryszpin P, Jachimowski P, Augustowski Ł, Ziarkiewicz M, Basak G, Lipowska M, Legatowicz-Koprowska M, Ziarkiewicz-Wróblewska B, Gawor-Prokopczyk M.   +8 more
europepmc   +1 more source

Amyloid Deposits in a Bone Marrow Biopsy Alongside a Presumed Causative Clone

eJHaem
Rahul Banerjee, Marie K. Das, Kelly D. Smith   +2 more
doaj   +1 more source

A retrospective study of isatuximab-pomalidomidedexamethasone in relapsed/refractory systemic AL amyloidosis. [PDF]

Haematologica
Vohra SR, Ravichandran S, Foard D, Martinez-Naharro A, Venneri L, Fontana M, Whelan CJ, Hawkins PN, Gillmore J, Lachmann HJ, Mahmood S, Wechalekar AD.   +11 more
europepmc   +1 more source